Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
News Release Digital Asset Direct

RESULTS FROM LATE STAGE BLADDER CANCER CLINICAL TRIAL CONDUCTED BY SUO-CTC ARE PUBLISHED IN THE LANCET ONCOLOGY

Society of Urologic Oncology

A breakthrough therapy discovered during Society of Urologic Oncology Clinical Trials Consortium (SUO-CTC) Phase 2 and 3 trials was published by The Lancet Oncology. The Lancet Oncology is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global policy, and inform constructive, positive change worldwide. The treatment, currently with the U.S. Food and Drug Administration (FDA) has the potential to offer physicians a new option in treating bladder cancer. It also has the potential to offer hope to those suffering from the disease. The Lancet Oncology paper, co-authored by Dr. Colin Dinney, Co-Founder of the SUO-CTC, provides significant details about the trial and its encouraging findings. The landmark U.S. clinical trial evaluated the investigational gene therapy, nadofaragene firadenovec. “As explained in our paper, the trials we conducted were designed to assess patients who suffer from high grade non-muscle-invasive bladder cancer and were unresponsive to previous treatments (BCG therapy). In the absence of such therapies, many of these patients face complete removal of their bladder due to the aggressive nature of the disease,” explained Dr. Dinney. “The development and testing of nadofaragene firadenovec is a prime example of an effective collaboration between the SUO-CTC and Pharma to develop the novel therapeutic as an alternative to surgical bladder removal.” During the Phase 2 and Phase 3 clinical trials conducted by the SUO-CTC, the treatment was administered to patients via a catheter, directly into the bladder. It is believed to work by helping the body produce high quantities of a protein that fights bladder cancer. “One of the advantages of nadofaragene firadenovec is that it has a favorable safety profile. We have demonstrated consistent efficacy in multiple trials. The other great advantage is the convenient treatment schedule,” Dr. Dinney continued. “With nadofaragene firadenovec, patients receive one dose every three months. This makes it very appealing to both physicians and patients.” “We believe the important clinical findings highlighted in The Lancet Oncology with this novel gene therapy may fulfill a significant unmet need for patients and have the potential to be practice-changing,” said Vijay Kasturi, MD, Vice President of Medical Affairs at FerGene, a gene therapy company committed to revolutionizing the treatment of bladder cancer. “We are extremely grateful to the investigators, the patients who participated in the study, and the SUO-CTC for the important findings highlighted in this publication.” Nearly 68,000 people in the United States are impacted by bladder cancer every year, making it one of the most common cancers. It also one of the deadliest cancers that will claim close to 18,000 lives in the US this year alone. In addition to bladder cancer trials, the SUO-CTC also collaborates in partnership with pharmaceutical and biotechnology companies to develop and conduct trials for prostate cancer and renal cancer. Created, owned, and operated by its members, the Society of Urologic Oncology Clinical Trials Consortium (SUO-CTC) is a clinical research investigator network of more than 400 members from more than 200 clinical sites in the U.S. and Canada. This national alliance of leading academic and community based uro-oncologists is committed to furthering urology research. The SUO-CTC is a registered 501c3 not-for-profit corporation and has a cooperative relationship with the Society of Urologic Oncology (SUO). ### Please visit http://www.suoctc.org For more information or to schedule an interview with a SUO-CTC spokesperson, please contact Dan Rene of kglobal at 202-329-8357 or daniel.rene@kglobal.com Contact Details Dan Rene +1 202-329-8357 daniel.rene@kglobal.com Company Website https://suoctc.org/about.aspx

December 02, 2020 09:00 AM Eastern Standard Time

LambdaTest raises US$6m, targeting a million users in 2021

Stockwood Strategy

Cloud-based browser testing platform LambdaTest today announced it has secured US$6 million in funding led by Sequoia Capital India’s Surge, a rapid scale-up program for startups in Southeast Asia and India. Blume Ventures, Entrée Capital and Leo Capital also participated in the round, along with Gokul Rajaram and Ramakant Sharma. With the platform, companies can test their website’s look, feel and performance on different browsers, operating systems and device combinations. Equally, in today’s development cycles where automation is crucial, it allows businesses to scale as their testing requirements grow. The fundraise will fast track LambdaTest’s mission of scaling its ecosystem and building the next-generation cloud infrastructure for the developer and tester community. The proliferation of devices and browsers has made it increasingly complex and fragmented for developers to test their websites and apps. Test automation is critical with today's agile development cycles, but building an in-house device lab can be prohibitively expensive for businesses. LambdaTest bridges this gap by allowing users to run both manual and automated tests on their websites and webapps across 2000+ different browsers and operating system environments. Since its launch, LambdaTest has been used to perform more than 12 million tests by its 350,000 users including individuals, SMEs and Fortune 500 companies such as Xerox, Cisco, Deloitte, Media.net, Coca Cola, Trepp, SurveyMonkey, Capgemini, HBR, Dashlane and Zoho. Founded in 2017 by Asad Khan and Jay Singh, LambdaTest is a testing infrastructure company that allows developers to seamlessly test their websites and apps on any browser or operating system environment. “Our ultimate goal is to bring the whole testing ecosystem to the cloud platform, where all testing processes are done in a seamlessly integrated infrastructure that is easy to scale up and helps for easy application, debugging, and ultimately helping to bring out the best quality products in the shortest amount of time,” said Asad Khan, co-founder & CEO, LambdaTest. The funding caps off a busy year for LambdaTest, which saw a huge increase in demand following the pandemic and the rapid migration to digital technologies - a trend that is here to stay. The company has seen 8-10% month-on-month growth in terms of sign-ups, customers, website visits, and revenue, and has more than 350,000 users from 132 countries using the platform. “This round of funding validates our efforts and strengthens our commitment to building a next-generation cloud infrastructure for the developer and tester community,” Khan added. Ends About LambdaTest LambdaTest is a testing infrastructure company that allows users to run both manual and automated tests on their websites and webapps across 2000+ different browsers, browser versions and operating system environments. The platform has been used to perform over 12 million tests in just three years, and is now being used by over 350,000 users across 132 different countries. About Surge Surge is Sequoia Capital India’s rapid scale-up program for startups in India and Southeast Asia. Surge combines $1 million to $2 million of seed capital with company-building workshops, a global curriculum and support from a community of exceptional mentors and founders. The program’s goal is to supercharge early-stage startups and give founders an unfair advantage, right out of the gate. For more information on Surge, visit www.surgeahead.com. Contact Details Bilal Mahmood +44 7714 007257 b.mahmood@stockwoodstrategy.com Company Website https://www.lambdatest.com/

December 02, 2020 07:00 AM Eastern Standard Time

Image

GoGetTested's End-to-End COVID-19 Response Operating System Scales Nationally, Provides Infrastructure to Unite the Private and Public Sectors

Go Get Tested

GoGetTested, the first end-to-end COVID-19 response platform in the country, exited beta today with more than 200,000 tests administered, and is scaling nationally. GoGetTested is currently available in Arizona, South Carolina, Washington D.C, Texas and, as of this week, Kansas. Over 10,000 Americans are now registering for tests via the platform each day. GoGetTested’s all-in-one testing solution offers free FDA-approved COVID-19 testing and delivers quick, accurate results for citizens. The company partners with local communities to make the testing, and public health process easy and accessible for everyone, regardless of geographic or socioeconomic status. The company’s operating system ensures a simple to manage digital experience for consumers, and public health professionals alike. Local residents schedule their COVID-19 test appointment online, complete the oral swab or saliva sample test in minutes at one of the testing sites, and have their results delivered via text or email within 48 hours. If a result is positive, a medical professional will call the patient to discuss their test results and suggested care next steps. For communities with existing COVID testing facilities in place, the GoGetTested platform is lab-agnostic, meaning that it can seamlessly integrate with existing healthcare platforms to create a citizen-friendly healthcare experience for local residents. "Our team has worked around the clock to develop the most innovative COVID-19 testing platform in the country--and one that provides a playbook for building out a public/private health infrastructure,” said Wellpay CEO Mohammad Gaber and a founding partner of GoGetTested. "I’m proud to officially exit out of beta today and look forward to serving tens of thousands of patients each day as we continue to grow. Our mission, since day one, has been to help as many citizens as possible and deliver the most accurate results. We believe that technology can play a critical role in the public health infrastructure of the future, our early results show what a modern digitally enabled public health experience can do to improve the health of our communities” As GoGetTested continues to scale nationwide, the company continues to forge innovative partnerships, including with Science 37, a clinical research company, to support continuing clinical vaccine trials. This partnership will support the research behind the vaccine’s efficacy. In addition, GoGetTested will also be supporting the scaled administration of the COVID-19 vaccine, utilizing its technology platform to ensure end-to-end vaccine and administration integrity. GoGetTested will continue to work with local communities across the country to set up COVID-19 testing sites. For more information on testing locations and to schedule a test, visit www.gogettested.com. About GoGetTested GoGetTested is the first national, digitally enabled Covid Response Operating System in the country with an end-to-end test scheduling and resulting management platform. Its complete COVID-19 testing experience will help keep the nation’s communities and economies open and safe. GoGetTested was founded as a unique public-private consortium of government, clinical, technology, lab, research and retail partners, including The consortium—which includes Precision Primary Care startup WellHealth, PE-backed Lab HealthTrackRx, event-management company Victory Marketing, inventory and warehouse management company Lead Commerce, and Silicon Valley-based healthcare fintech startup Wellpay. Its Covid-19 response units ensure geographical reach to rural areas and fast activation in virus hotspots. Testing is free for anyone and provides the most complete, adaptive and secure testing services nationwide. Contact Details April White +1 323-216-8589 gogettested@trustrelations.agency Company Website https://www.gogettested.com/

December 01, 2020 08:08 AM Eastern Standard Time

Let’s Dive lands US$1.7m to make remote working more human, tackling concerns of worker isolation

Stockwood Strategy

Let’s Dive a platform for remote employee engagement and building team culture has today announced it has raised US$1.7 million in funding led by Sequoia Capital India’s Surge. The funding round also saw participation from Village Global and several angel investors*. Let’s Dive will use the funding to further build experiences on the platform to help remote teams tackle isolation, distribute the product to thousands of companies around the world and build a cross-border product team. The on-going global pandemic has upended traditional ways of working, forcing businesses all around the world to set themselves up remotely. Let’s Dive’s founders, who have been building solutions for remote teams for over five years, know from experience that isolation and the lack of team bonding are the biggest obstacles to successfully sustaining a remote work culture. Let’s Dive is a platform that eliminates isolation by bringing teams together and recreating a social space where participants can connect through a range of exciting activities. This creates deeper bonds amongst remote teams who lack the advantage of personal connections. Teams can play games like poker, pictionary, icebreakers, trivias, chess, card games and organise YouTube watch parties. Let’s Dive has already attracted over 100 teams from 28 countries to its platform. Businesses currently using the platform include teams from Silicon Valley giants like Facebook, Airtable, and in India, some of the biggest tech companies like Swiggy and Hike. Currently, Let’s Dive is an invite-only experience. Companies can apply for access on www.letsdive.io. “Having founded and run one of the first 100% remote working businesses, I have personally seen the importance of togetherness and team camaraderie as core pillars of company culture. Remote working poses a significant challenge for businesses trying to maintain this. With Let’s Dive, we set out to solve this problem and drive real engagement and interaction amongst colleagues online,” said Nitesh Agrawal, Co-Founder, Let’s Dive. “Let’s Dive has already gained strong traction and attracted hundreds of teams to our platform - without any marketing. The product’s experience is so unique that teams feel connected within a few hours of usage. With the funding and partnership from Sequoia Capital India’s Surge, as well as investors such as Village Global, we look forward to rolling out Let’s Dive to businesses globally to help them create the best possible remote team culture.” added Nitesh. The company was founded in July 2020 by Nitesh Agrawal and Om Prakash. Both have had previous experience with building and scaling startups and have worked with startups like Housing.com, Ola, Mykarma, Fitzoo. Before Let’s Dive, Nitesh led Indiez as founder and CEO, where he built a community of 10,000+ engineers from 50+ countries and was one of the first 100% remote organisations. Ends *Along with the marquee investors, top tier angels such as Utsav Somani from iSeed, Akhil Paul, Anand Chandrasekharan (Former Snapdeal CPO and Facebook Director of Messenger), Zvi Band (Founder, Contactually), Job Van (Founder, Remote.com), Ravish Naresh (Founder, Khatabook), Sai (Founder, Mobile Premier League), Cecilia Stallsmith, Sunita Mohanty (Facebook), OnDeck community and Kamir Kothari (SVB) also participated in the round. About Let’s Dive Let’s Dive is on a mission to build togetherness for businesses with remote working teams. The SaaS platform provides a social space for remote teams, and aims to help companies build their culture through fostering better human connections. Let’s Dive users can hang out, play games, or watch videos, all while sharing their audio and video with their colleagues. For more information, visit: https://www.letsdive.io/ About Surge Surge is Sequoia Capital India’s rapid scale-up program for startups in India and Southeast Asia. Surge combines $1 million to $2 million of seed capital with company-building workshops, a global curriculum and support from a community of exceptional mentors and founders. The program’s goal is to supercharge early-stage startups and give founders an unfair advantage, right out of the gate. For more information on Surge, visit www.surgeahead.com. Contact Details Bilal Mahmood +44 7714 007257 b.mahmood@stockwoodstrategy.com Company Website https://www.letsdive.io/

December 01, 2020 07:00 AM Eastern Standard Time

Image

SullivanCotter Partners with Ntracts to Integrate Health Care Contract Management Solution Into Growing Suite of Technology Products

SullivanCotter

SullivanCotter, the nation’s leading independent consulting firm in the assessment and development of total rewards programs, workforce solutions, and technology and data products for the health care industry and not-for-profit sector, has partnered with Ntracts, a premier health care contract management solution, to incorporate full-scale contract lifecycle management as part of its comprehensive Provider Performance Management Technology™ (PPMT) platform. PPMT™ is an industry-first, cloud-based solution that enables engagement and alignment of the clinical workforce through the automation of performance-based compensation administration, analytical and reporting capabilities. Ntracts allows organizations to mitigate contract compliance risk and streamline the contracting process across the entire enterprise. Designed to address a spectrum of physician, leadership and other key administrative needs, PPMT™ delivers centralized and actionable data tailored to the unique needs of each stakeholder. It combines years of health care compensation insight and expertise with an intuitive, automated technology platform, and serves as a single source of truth that helps empower physicians to drive desired outcomes and enhance organizational performance. Ensuring that physician employment agreements align with system-wide compensation terms and payments remains a challenge for health care organizations nationwide. With the addition of Ntracts, PPMT™ will include a cutting-edge contract lifecycle management component that will provide hospitals and health systems with an accurate and comprehensive view of clinical employment contracts across the organization in real-time. By effectively integrating the compensation, performance and contract lifecycle management process into one centralized platform, PPMT™ will help to drive results through greater alignment, transparency and insight. “Health care continues to evolve at a rapid pace, and there are number of complex moving parts to navigate as it relates to physician compensation and performance. By adding critical contract management capabilities to help health care organizations reduce risk, maintain compliance with changing regulatory requirements, and improve operational efficiency, PPMT™ will be a full-scale solution designed to support the transition from volume to value-based care,” said David Schwietz, Chief Information Officer, SullivanCotter. David Paschall, Chief Executive Officer of Ntracts, adds, “SullivanCotter shares our commitment to quality and we are proud to combine our industry-leading contract lifecycle management solution with SullivanCotter’s expertise in physician compensation and performance. Together we can offer an unmatched, end-to-end technology solution to support health care organizations as they work to drive change and deliver long-term, sustainable results in this quickly evolving environment.” For more information on Provider Performance Management Technology™, visit our website at www.sullivancotter.com/PPMT or contact us at 888.739.7039. About SullivanCotter SullivanCotter partners with health care and other not-for-profit organizations to understand what drives performance and improve outcomes through the development and implementation of integrated workforce strategies. Using our time-tested methodologies and industry-leading research and information, we provide data-driven insights, expertise, data and technology products to help organizations align business strategy and performance objectives – enabling our clients to deliver on their mission, vision and values. About Ntracts Ntracts, Inc. offers a software-as-a-service application that enables users to originate, search for and report on contracts. The application also accelerates the contract review and approval process by automatically notifying responsible parties of contract requests, approaching expiration dates and other critical performance milestones, saving clients both time and money. Ntracts, Inc. is based in Indianapolis, Indiana, and was founded by Hall, Render, Killian, Heath & Lyman, the nation's leading health care law firm. Contact Details Becky Lorentz +1 314-414-3719 beckylorentz@sullivancotter.com Company Website https://sullivancotter.com/

November 30, 2020 07:55 AM Eastern Standard Time

Travelling More Safely During the Holidays: Steps You Can Take to Reduce Your Risk

D S Simon Media

While the CDC recommends that you reduce your risk of contracting or spreading COVID by avoiding travel, there is recognition that many families will be gathering during Thanksgiving and the holiday season. What are some things they can do to reduce their risk? Emmy-Award winning medical journalist Dr. Bob Arnot conducted a nationwide media tour with AIrQueen.com to discuss tips, advice and resources to help increase safety. During the nationwide media tour Dr. Bob Arnot highlighted: The latest recommendations from the CDC to reduce risk when traveling Tips for proper mask wearing including when to change them and what you need to know to protect yourself in addition to protecting others Proper methods for staying sanitized Gift ideas to help keep your family safe during the holidays The AirQueen is made with a highly advanced nano-fiber material to provide extreme protection with a minimum of 95% protection and an average in excess of 97% particle filtration (see the Nelson Labs reports on the website for more details). The nano-filter allows extreme breathability and comfort which, in addition to the excellent protection provided, is one of its strong value propositions. Another major advantage of the AirQueen mask is that it can be cleaned up to 10 times with a simple 75% ethanol spray wash (also available on AirQueen.com) making it the most protective mask available which is also affordable. Even better is that the AirQueen is allowed to be sold to the general public which means you can provide the highest level protection for you and your family and loved ones. Lastly there is also a highly protective kids version, the Airbon mask, which is made from the same filter and manufacturing process as the AirQueen making it one of the safest masks for children on the market. About YourUpdateTV: YourUpdateTV is a social media video portal for organizations to share their content. It includes separate channels for Health and Wellness, Lifestyle, Media and Entertainment, Money and Finance, Social Responsibility, Sports and Technology. Media Contact: Michael O’Donnell D S Simon Media 212-736-2727 modonnell@dssimon.com Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

November 24, 2020 10:05 AM Eastern Standard Time

Video

How to Avoid Leaving Benefits on the Table

D S Simon Media

Navigating health plan offerings can be challenging, so it’s important for consumers to understand whether they qualify for more benefits that may help save money and improve health, which can help provide for a more secure and active future as a person ages. Recently, Dr. Stephen Cha, the Chief Medical Officer at UnitedHealthcare Community & State, teamed with YourUpdateTV on a satellite media tour to explain how people can qualify for a dual complete plan. A video accompanying this announcement is available at: https://youtu.be/MpNGLmYGmnA People who have Medicare and find that money is tight may qualify for a UnitedHealthcare Dual Complete plan – a dual special needs health plan, which may allow them to get better benefits, including dental, hearing and vision coverage at no extra charge. It can also include credits to buy healthy food and help purchase approved health items. Although requirements vary from state to state and by circumstances, if you are a family of one making less than $16,000 a year or a family of 2 making less than $21,000 a year, you may qualify. You will also have someone to help you manage and coordinate your care to help manage through health concerns, which is so important during this pandemic. Putting off care, especially annual wellness visits, can leave health risks undiagnosed and untreated. People eligible for a dual plan can usually enroll for no monthly premium, which may make it an affordable option. These plans are designed for people with low income who could use some extra help because of disabilities, health conditions or age. To learn if you are eligible and getting the most of your benefits, visit http://www.getdual.com or call 1-855-799-3199. About Dr. Stephen Cha Dr. Stephen Cha is Chief Medical Officer of UnitedHealthcare Community & State, where he oversees clinical strategies and programs while acting as the liaison for critical clinical initiatives. He also plays a key role in clinical thought leadership and serves as a subject matter expert in care decisions throughout Community & State. Prior to joining UnitedHealthcare, Dr. Cha served as the Group Director in the State Innovation Group at the Center for Medicare & Medicaid Innovation (CMMI). He has also served as the Chief Medical Officer at the Center for Medicaid & CHIP Services (CMCS), and is a practicing physician. Dr. Cha has a strong background in dynamic health policy thought leadership, health care transformation, and quality reporting. About YourUpdateTV: YourUpdateTV is a social media video portal for organizations to share their content. It includes separate channels for Health and Wellness, Lifestyle, Media and Entertainment, Money and Finance, Social Responsibility, Sports and Technology. Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

November 24, 2020 10:00 AM Eastern Standard Time

Video

Supporting Doctors on the Frontlines: How to Become an “Ally of Doctors”

D S Simon Media

2020 has been a tough year, and doctors and healthcare professionals have been working hard on the front lines – more than ever before. While the coronavirus pandemic has upended life for nearly everyone, healthcare workers and doctors have had to face more risks than most. So many of us are in awe of how these professionals still care for patients despite tremendous challenges. Mucinex is rallying Americans coast to coast to become an “Ally of Doctors” to show health care professionals and frontline heroes how much we support, appreciate, and trust them. With only 16% of consumers having reviewed their doctor in the past 12 months, Mucinex is making a nationwide call to action for patients to give back to those who have helped them get better by advocating for their doctors and health care professionals. Consumers are encouraged to review and recommend their own trusted doctors and health care professionals, providing them with the admiration and support they are deserving of, and helping them build a more robust patient network. For every new doctor review left on Healthgrades.com, Mucinex will donate $20 to the United Negro College Fund (UNCF), with the goal of donating $20,000 to the next generation of frontline heroes by the end of 2020. This is in addition to Mucinex parent company, RB’s larger pledge of donating 100 scholarships to UNCF – the nation’s most successful minority higher education organization. This support will benefit the organization’s hard-working students who aspire to become the next generation of frontline heroes. Consumers can visit Mucinex.com for more information and Healthgrades.com to review their doctor. About YourUpdateTV: YourUpdateTV is a social media video portal for organizations to share their content. It includes separate channels for Health and Wellness, Lifestyle, Media and Entertainment, Money and Finance, Social Responsibility, Sports and Technology. Media Contact: Michael O’Donnell D S Simon Media 212-736-2727 modonnell@dssimon.com Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

November 23, 2020 01:16 PM Eastern Standard Time

Video

CIPIO.ai completes a $1.25M pre-seed round in stealth mode to accelerate R&D for AI-Infused Customer Intelligence Platform

CIPIO.ai

CIPIO co-founders Growson Edwards (Ex-MicroPact CCO), Manoj Kumar Goyal ( Ex-Marketo CPO and Ex-Oracle GVP), and Dharm esh Trivedi ( Ex-Motionsoft SVP ) announced the completion of their pre-seed round of $1.25M, led by DX.Partners, a pre-seed Venture Studio, with participation from the co-founders and other angel investors. DX.Partners Founder & Managing Partner, Sundeep Sanghavi (ex-CEO & Founder of DataRPM, acquired by Progress Software (NASDAQ: PRGS)) is very bullish on the founders’ vision and focus on the B2C member/subscriber intelligence. “COVID-19 has accelerated the unprecedented changes in consumer behavior, causing massive disruption in the traditional brick & mortar industries like fitness, faith & spirituality, restaurants, live event venues, who now must transform digitally at an exponential pace,” said Sanghavi. Mr. Trivedi has scaled multiple startups from zero to $100M in revenue with two exits, Razorsight acquired by Synchronoss (NASDAQ: SNCR) and MotionSoft acquired by Daxco. “We have been heads down since the pandemic working on a minimum valuable product and have made tremendous progress,” said Trivedi. With our insights and industry expertise, early adopters like Crunch Fitness, World’s Gym, and the Xponential Fitness streaming platform called GO, which operates brands like Pure Barre, Club Pilates, AKT, YogaSix, Cyclebar, Row House, Stretch Lab, and Stride have seen significant ROI.” Mr. Trivedi reached out to Growson Edwards, an advisor at that time, to methodically launch CIPIO out of stealth mode. Mr. Edwards led MicroPact’s growth from $1M to $84M in revenue and has a knack for customer success resulting in a 106% net dollar retention. “I have launched and scaled five SaaS products across multiple markets. As an early advisor, I saw immense value in CIPIO’s IP, inspiring me to join Dharmesh and invest in the pre-seed round,” said Edwards. He quickly sought out San Francisco Bay area veteran MarTech platform executive Manoj Kumar Goyal to lead CIPIO’s R&D team. Mr. Goyal previously led Oracle’s Customer Data Platform (CDP) team and launched the platform in a record time of 12 months. Before Oracle, Mr. Goyal served as Marketo’s Chief Product Officer, meeting the performance and scalability needs of the most demanding CMOs (such as Google, AWS, and Microsoft), and driving annual revenue growth at a 25% pace to $300m+ revenue for 5000+ customers. “Whether you are a massive franchisor or the operator of a neighborhood corner gym, a church, a restaurant, or venue, the pandemic has impacted one and all like never before. All the idling forced by the novel coronavirus has necessitated that brick & mortar businesses go digital at warp speed. What’s lost in this rapid digital transformation is understanding the customer beyond the 360-degree intelligence that traditional CDPs provide. To understand the customer journey in this new hybrid world will require unparalleled intelligence that can only be produced by combining the power of AI & domain expertise,” said Mr. Goyal. “It’s very rare for a startup at a stealth stage to have such a strong customer validation along with a killer team,” said Sanghavi. CIPIO expects to launch commercially in Q1 of 2021 and expects to raise additional capital at that time. Contact Details Jennifer Isaac +1 315-398-9541 Jennifer@CIPIO.ai Company Website https://cipio.ai/

November 19, 2020 12:30 PM Eastern Standard Time

Image

1 ... 288 289 290 291 292 ... 305